Buy $ACOR - NRPicks 12 Nov Long

Description

⋅ Nov 12, 2021 8:15 PM

Acorda Therapeutics, Inc. a biopharmaceutical company, develops and markets therapies for neurological disorders in the United States. The company markets Ampyra , an oral medication to improve gait in patients with multiple sclerosis (MS).

Trade closed: stop reached

⋅ Dec 2, 2021 4:37 PM

Nov 22